DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walle, U. K.
Right arrow Articles by Walle, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walle, U. K.
Right arrow Articles by Walle, T.

Vol. 30, Issue 5, 564-569, May 2002

Induction of Human UDP-Glucuronosyltransferase UGT1A1 by Flavonoids---Structural Requirements

U. Kristina Walle and Thomas Walle

Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, South Carolina

Recent studies in our laboratory in the human hepatic and intestinal cell lines Hep G2 and Caco-2 have demonstrated induction of UGT1A1 by the flavonoid chrysin (5,7-dihydroxyflavone) using catalytic activity assays and Western and Northern blotting. In the present study, we examined which features of the flavonoid structures were associated with induction of UGT1A1 and whether common drug-metabolizing enzyme inducers also produce this induction. We also determined whether flavonoid treatment affected sulfate conjugation and CYP1A1 activity. We used intact Hep G2 cells for these studies, with chrysin as the model substrate. Both glucuronidation and sulfation were measured. Hep G2 cells were pretreated for 3 days with 25 µM concentrations of 22 flavonoids (n = 4-12). Only four flavonoids demonstrated induction of glucuronidation similar to that of chrysin (i.e., 3-5-fold in the intact cells). These were acacetin, apigenin, luteolin, and diosmetin, all of which, like chrysin, are 5,7-dihydroxyflavones with varying substituents in the B-ring. 5-Hydroxy-7-methoxyflavone and 5-methyl-7-hydroxyflavone produced a modest 1.5 to 2-fold induction, whereas all other flavonoids examined were without effect. None of the flavonoids caused more than a modest change in sulfation activity (60-140% of control). In contrast, all tested 5,7-dihydroxyflavones and -flavonols induced CYP1A1 activity (ethoxyresorufin deethylation). Of seven common drug-metabolizing enzyme inducers only 3-methylcholanthrene and oltipraz showed modest induction of chrysin glucuronidation but not 2,3,7,8-tetrachlorodibenzo-p-dioxin or phenobarbital. Together, these results strongly suggest that the flavonoid induction of UGT1A1 is through a novel nonaryl hydrocarbon receptor-mediated mechanism.

Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Cancer Prevention ResearchHome page
S. L. Navarro, S. Peterson, C. Chen, K. W. Makar, Y. Schwarz, I. B. King, S. S. Li, L. Li, M. Kestin, and J. W. Lampe
Cruciferous Vegetable Feeding Alters UGT1A1 Activity: Diet- and Genotype-Dependent Changes in Serum Bilirubin in a Controlled Feeding Trial
Cancer Prevention Research, April 1, 2009; 2(4): 345 - 352.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
S. Mirkov, B. J. Komoroski, J. Ramirez, A. Y. Graber, M. J. Ratain, S. C. Strom, and F. Innocenti
Effects of Green Tea Compounds on Irinotecan Metabolism
Drug Metab. Dispos., February 1, 2007; 35(2): 228 - 233.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
C. M. Smith, R. A. Graham, W. L. Krol, I. S. Silver, M. Negishi, H. Wang, and E. L. Lecluyse
Differential UGT1A1 Induction by Chrysin in Primary Human Hepatocytes and HepG2 Cells
J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1256 - 1264.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
X. Wen, U.K. Walle, and T. Walle
5,7-Dimethoxyflavone downregulates CYP1A1 expression and benzo[a]pyrene-induced DNA binding in Hep G2 cells
Carcinogenesis, April 1, 2005; 26(4): 803 - 809.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
V. Svehlikova, S. Wang, J. Jakubikova, G. Williamson, R. Mithen, and Y. Bao
Interactions between sulforaphane and apigenin in the induction of UGT1A1 and GSTA1 in CaCo-2 cells
Carcinogenesis, September 1, 2004; 25(9): 1629 - 1637.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
M. G. Soars, D. M. Petullo, J. A. Eckstein, S. C. Kasper, and S. A. Wrighton
AN ASSESSMENT OF UDP-GLUCURONOSYLTRANSFERASE INDUCTION USING PRIMARY HUMAN HEPATOCYTES
Drug Metab. Dispos., January 1, 2004; 32(1): 140 - 148.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. Hu, J. Chen, and H. Lin
Metabolism of Flavonoids via Enteric Recycling: Mechanistic Studies of Disposition of Apigenin in the Caco-2 Cell Culture Model
J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 314 - 321.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M.-F. Yueh, Y.-H. Huang, A. Hiller, S. Chen, N. Nguyen, and R. H. Tukey
Involvement of the Xenobiotic Response Element (XRE) in Ah Receptor-mediated Induction of Human UDP-glucuronosyltransferase 1A1
J. Biol. Chem., April 18, 2003; 278(17): 15001 - 15006.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. Chen, H. Lin, and M. Hu
Metabolism of Flavonoids via Enteric Recycling: Role of Intestinal Disposition
J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1228 - 1235.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.